Most Read News


Strong countermeasures to EZmedicom’s invasion into distribution field

It was criticized EZmedicom, a contract organization for medical institutes’ electronic bidding system, went too far on invading the distribution field. The Korea Pharmaceutical Distribution Association(Chi-Yup Hwang...

Will ‘Vemlidy’ become a new power in chronic hepatitis B treatment market?

Pharmaceutical companies have been highly competitive to develop new chronic hepatitis B treatments. In the competition, Gilead developed a new drug called ‘Vemlidy(generic name: tenofovir alafenamide, aka. TAF)’ and ...

1 of 3 incrementally modified drugs were antihypertensive

Since the adoption of the Incrementally Modified Drug Approval System in 2009, the total 82 pharmaceutical products were approved as incrementally modified drug, 1 of 3 modified drugs were antihypertensive. According...

‘Standard of Aggregation Label’ proposed

‘Standard of Aggregation Label’ was revealed before enforcement of the serial number reporting system on pharmaceutical wholesalers from the coming 1st of July. After going through expert meetings with people concern...

Last year’s medical device manufacturing performance was KRW 5.6025 trillion, increased by 12%

The last year’s manufacturing performance of medical devices was KRW 5.6025 trillion increased by 12% compared to 2015. A type of medical device that was manufactured the most was dental implant with KRW 840.7 billion...

It is necessary to develop evaluations based on medical records

A policy debate for the National Health Insurance was held at the National Assembly to improve quality of medical services in Korea, and a shift of paradigm for its deliberation and evaluation system. Sponsored by th...

More pharma sales reps having multiple jobs

It seems there are more sales representatives having multiple jobs at pharmaceutical companies. While having sales activities for products of the company they belong, these representatives are making extra earnings b...

Who are candidates for Moon administration’s first Minister of Health and Welfare?

It was told there was a high chance for the Jae-In Moon administration’s first Minister of Health and Welfare to be Rep. Yong-Ik Kim, a director of democracy research at The Minjoo Party. Since President Moon promise...

Amplified concerns for delivery problem and return crisis after enforcement of serial number system

While there is only a month left for enforcement of the real-time serial number reporting system, there have been worries about delivery problems and crisis of return to medical institutes, such as pharmacies. When i...

Approval trend of OTC medicines turns to ‘increase’ this year

Acquiring an increasing number of OTC products this year, pharmaceutical companies were analyzed to secure growth engines by energizing their OTC products. According to the Ministry of Food and Drug Safety, there wer...

228 new drug approvals after 2010, 13 of them developed by Korea

There have been 228 products approved as new drug in Korea since 2010, and 13 of them were developed by Korean pharmaceutical companies. According to the Ministry of Food and Drug Safety, the number of new drugs appr...

KMA benefits from highest rate of increase at 2018 health insurance benefit negotiation

The 2018 health insurance benefit negotiation continued to be a war of nerves even at the end, but ‘all the categories’ were finally completed like the last year. The Korean Medical Association(KMA) dramatically conc...

Discussions about determining structure for health insurance benefits

A place was prepared to discuss about improvements in the determining structure for health insurance benefits, which attract sharp attention of the pharmaceutical industry, and to collect opinions from the field. Dir...

KOSDAQ’s 1st quarter sales growth rate 4 times higher than KOSPIA

It was observed the KOSDAQ listed pharmaceutical companies’ year-on-year average sales growth rate of the 1st quarter was 4 times higher than the ones of KOSPI listed pharmaceutical companies. On the other hand, KOSPI...

Court rules probation on pharmaceutical company chairman for tax evasion

On the 29th, the Seoul Central District Court ruled 2 years and 6 months of prison and 3 years of probation on a pharmaceutical company chairman for approximately KRW 3.6 billion tax evasion using stocks issued for a ...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.